OptimizeRx

OPRX · NASDAQ

$8.93+$0.19 (+2.17%)TodayMarket closed ·
Prev close $8.74

About OPRX

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

Employees
104
Headquarters
Waltham, Massachusetts
Listed
May 18, 2005
Sector
Health Care
Industry
Health Care Technology

OPRX key statistics

Market cap
164.63M
Price-earnings ratio
38.00
Dividend yield
—
Average volume
182.80K
Volume
157.75K
Open price
$8.71
High today
$9.08
Low today
$8.57
52 Week high
$22.25
52 Week low
$4.54

OptimizeRx (OPRX) at a glance

OptimizeRx (OPRX) last traded at $8.93, with a market cap of 164.63M and a price-to-earnings ratio of 38.00.

Today the stock has traded between $8.57 and $9.08. The current price is 4.2% above the day's low and 1.7% below its high.

Volume so far is 157.75K shares, in line with the average of 182.80K shares a day.

Over the past year OptimizeRx has ranged from $4.54 to $22.25, and now sits 25% of the way up that range.

OptimizeRx met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.16 per share against an estimate of $0.0796.

The average analyst price target is $12.85, 43.9% above the current price, from 7 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

86%of 7 analyst ratings say Buy
  • Buy85.7%
  • Hold14.3%
  • Sell0.0%
Price target · 7 analystsAvg $12.85
Low
$11.11
Now
$8.93
High
$18.90

OPRX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 319.5% on average.

  1. Q3 FY24: reported $0.12 per share against an estimate of $0.0629
  2. Q4 FY24: reported $0.30 per share against an estimate of $0.2767
  3. Q1 FY25: reported $0.08 per share against an estimate of -$0.1224
  4. Q2 FY25: reported $0.24 per share against an estimate of $0.0175
  5. Q3 FY25: reported $0.20 per share against an estimate of $0.0452
  6. Q4 FY25: reported $0.51 per share against an estimate of $0.2312
  7. Q1 FY26: reported $0.14 per share against an estimate of -$0.0393
  8. Q2 FY26: reported $0.16 per share against an estimate of $0.0796

OPRX news

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • OptimizeRx Reports Q1 2026 Results: Full Earnings Call Transcript

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releaseBusiness Wire

    Myomo Appoints William J Febbo to its Board of Directors

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Assessing OptimizeRx: Insights From 4 Financial Analysts

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

Similar companies

Companies in the same industry as OptimizeRx

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.